Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Stock factor profile

SANOFI

SANOFI · Healthcare · Pharmaceuticals & Biotechnology

Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 3,530 full-time employees. The firm is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. The company has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. The company sells its products through independent distributors primarily in India. The company also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

Last price₹3190.80
1 day+1.06%
1 month-5.65%
Model ratingLocked
Data as of04 Sep 2026

Performance

Price history

Equity review factors

Factor profile

Factor scores are part of the Wright portfolio review.

Run your free portfolio review

Fundamental snapshot

Fundamentals at a glance

Market cap7669
P/E ratio23.4
Factor betaLocked
VolatilityLocked
Model scoreLocked
Screen passLocked

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.